An open-label multicenter study to assess the safety of dextromethorphan/quinidine in patients with pseudobulbar affect associated with a range of underlying neurological conditions

Survival Analysis of Irish Amyotrophic Lateral Sclerosis Patients Diagnosed from 1995–2010

(2013) James Rooney et al.   PLoS One

Pseudobulbar Affect: Burden of Illness in the USA

(2012) Jennifer Colamonico et al.   ADVANCES IN THERAPY

Pseudobulbar affect: an under-recognized and under-treated neurological disorder

(2011) Susan S. Work et al.   ADVANCES IN THERAPY

Causes and place of death in Italian patients with amyotrophic lateral sclerosis

(2010) R. Spataro et al.   ACTA NEUROLOGICA SCANDINAVICA

Dextromethorphan Plus Ultra Low-Dose Quinidine Reduces Pseudobulbar Affect

(2010) Erik P. Pioro et al.   ANNALS OF NEUROLOGY

Neuroanatomy of Pathological Laughing and Crying: A Report of the American Neuropsychiatric Association Committee on Research

(2009) J. Parvizi et al.   JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES

Pathological Laughing and Crying

(2008) Hal S Wortzel et al.   CNS DRUGS

Causes of death amongst French patients with amyotrophic lateral sclerosis: a prospective study

(2008) J. Gil et al.   EUROPEAN JOURNAL OF NEUROLOGY

Increasing incidence of ALS in Canterbury, New Zealand: A 22-year study

(2008) M. Murphy et al.   NEUROLOGY

Inappropriate crying and laughing in Parkinson disease and movement disorders

(2008) Mustafa S. Siddiqui et al.   WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY

Analysis of survival and prognostic factors in amyotrophic lateral sclerosis: a population based study

(2007) S Zoccolella et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues

(2007) G Logroscino et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY